CAJ | 학술논문

目的：研究阿昔洛韦在病毒性肺炎治疗中的应用效果。方法搜集2013年9月～2014年我院接收的病毒性肺炎76例患者，按照就诊日期单双号分为甲组和乙组，其中甲组38例阿昔洛韦治疗，乙组38例利巴韦林治疗。观察并对比甲组和乙组的临床效果。结果与乙组相比，甲组症状及体征评分较低，治疗有效率较高，不良反应较少，差异有统计学意义（P<0.05）。结论阿昔洛韦对病毒性肺炎治疗效果显著。
목적：연구아석락위재병독성폐염치료중적응용효과。방법수집2013년9월～2014년아원접수적병독성폐염76례환자，안조취진일기단쌍호분위갑조화을조，기중갑조38례아석락위치료，을조38례리파위림치료。관찰병대비갑조화을조적림상효과。결과여을조상비，갑조증상급체정평분교저，치료유효솔교고，불량반응교소，차이유통계학의의（P<0.05）。결론아석락위대병독성폐염치료효과현저。
Objective The efficacy of Acyclovir application in treatment of viral pneumonia is to be investigated. Methods Chose 76 viral pneumonia patients who were treated in hospital from September 2013 to 2014 and separated them into group A and group B according to hospitalization date number (odd number and even number). 38 patients in group A were given Acyclovir treatment, while 38 patients in group B were given Ribavirin treatment, and then observed and compared the treatment efficacy of the two groups. Results Compared to group B, the patients’ illness symptoms and physical sighs scored less than their counterparts in group A, besides, the treatment efficiency was much higher in group A with less side effects, there was a treatment differential between the two groups, and such a differential had statistic value(P<0.05). Conclusion The Acyclovir treatment is of clinical efficiency and significance to cure viral pneumonia with. Thus, such a treatment approach is quite worthwhile to be promoted and applied.